Algerian study aims to simplify diagnosis of rare swelling disorder
NCT ID NCT07293364
Summary
This study aims to see if a simpler blood test that measures just one protein function can accurately diagnose hereditary angioedema (HAE), a rare condition causing sudden, serious swelling. Researchers in Algeria will compare this new test approach to the standard combination of tests currently used. The study will involve 514 people who either have symptoms suggesting HAE or are family members of someone with HAE.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA (HAE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
EPH de Rouiba (Etablissement Public Hospitalier)
Algiers, 16017, Algeria
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.